Alivation Research, LLC | ClinicalTrials HQ

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response	Depressive Disorder, Treatment-Resistant, depressive disorder, major depressive disorder, mood disorder, psychiatric disorder	Recruiting	Phase 2	2026-10-05		NCT07284667
ACP-204 in Adults With Alzheimer's Disease Psychosis	Hallucinations, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nervous system disorder, perceptual disorders	Recruiting	Phase 2 / Phase 3	2026-10-05		NCT06159673
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine	Ear Diseases, Nausea, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Photophobia, Sensation Disorders, Signs and Symptoms, Signs and Symptoms, Digestive, brain disorder, central nervous system disorder, eye disorder, headache disorder, hearing disorder, hyperacusis, hypnic headache, migraine disorder, nervous system disorder, otorhinolaryngologic disease, vision disorder	Recruiting	Phase 3	2026-09-24		NCT04743141
RESEARCH EVALUATING VAGAL EXCITATION AND ANATOMICAL LINKS	brain disorder, central nervous system disorder, depressive disorder, epilepsy, mood disorder, nervous system disorder, psychiatric disorder	Active, not recruiting	Not applicable	2026-09-03		NCT06143293
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression	Depressive Disorder, Treatment-Resistant, depressive disorder, mood disorder, psychiatric disorder	Recruiting	Not applicable	2026-06-15		NCT03887715